|
This would be a powerhouse company and then a move into Biogenerics with Artharitis alone is a 9 billion market which will be the first entry according to IMF.
Par's earnings and revs are shooting up nicely Sentiment : Strong Buy Rating :
 (No ratings) |
Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.03